Managing thrombotic risk in patients with diabetes

HIGHLIGHTS

• who: A. John Camm from the (UNIVERSITY) have published the Article: Managing thrombotic risk in patients with diabetes, in the Journal: (JOURNAL)
• what: Progress has been made in the development of pharmacological therapies for the prevention of CV events in patients in sinus rhythm with diabetes and CAD and/or PAD, as well as in patients with diabetes and AF.
• future: Each of the four NOACs are recommended for patients with a ­C HADS2 score of ≥ 2 in the Japanese Circulation Society guidelines for AF while apixaban and dabigatran are recommended for patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.